Icares Medicus Inc (6612) — Cash Flow Reinvestment Rate

Latest as of June 2025: 0.40x

Icares Medicus Inc (6612) has a Cash Flow Reinvestment Rate of 0.40x as of June 2025, reinvesting NT$44.14 Million (capex NT$20.18 Million plus investments NT$-23.96 Million) from operating cash flow of NT$111.22 Million. Explore how much does Icares Medicus Inc reinvest in capital to see what proportion of operating cash flow is directed to capital expenditures.

Reinvestment Rate

0.40x
(Capex + Investments) / Operating CF

Total Reinvested

NT$44.14 Million
Capex + Investments

Operating Cash Flow

NT$111.22 Million
TWD

Capital Expenditures

NT$20.18 Million
TWD

Icares Medicus Inc Cash Flow Reinvestment Rate (2017–2022)

Historical reinvestment intensity for Icares Medicus Inc across 6 annual periods. Also explore Icares Medicus Inc balance sheet assets for the complete picture of this company's asset base.

Annual Cash Flow Reinvestment Rate for Icares Medicus Inc (2017–2022)

Year-by-year capital reinvestment analysis for Icares Medicus Inc. For live market cap and broader valuation context, see 6612 company net worth.

Year Reinvestment Rate Total Reinvested (TWD) Operating CF Capex YoY Change
2022 1.56x NT$201.10 Million NT$128.92 Million NT$34.03 Million ▼ -65.3%
2021 4.50x NT$173.55 Million NT$38.57 Million NT$6.48 Million ▲ +348.7%
2020 1.00x NT$71.57 Million NT$71.37 Million NT$11.20 Million ▼ -42.1%
2019 1.73x NT$153.79 Million NT$88.78 Million NT$93.41 Million ▲ +1097.3%
2018 0.14x NT$9.15 Million NT$63.22 Million NT$6.08 Million ▼ -42.9%
2017 0.25x NT$11.52 Million NT$45.47 Million NT$8.44 Million
Cash Flow Reinvestment Rate = (ABS(Capex) + ABS(Investments)) / Operating Cash Flow